Each year on March 31st, #WorldTheranosticsDay honors Dr. Saul Hertz’s contributions to the molecular therapy field and the first therapeutic administration of radioiodine to a patient. Since this milestone, innovation in theranostics has come a long way; a recent renaissance in the space has many viewing radiopharmaceuticals as the next scientific frontier. At #Lantheus, we are focused on advancing our capabilities as the leading radiopharmaceutical-focused company through a diversified pipeline with the potential to help deliver better patient outcomes. Learn more about our pipeline: https://bit.ly/42HhGY9 #LeadingRadiopharma
